Buoniconti Fund to Cure Paralysis Inc.
of Private Matching Funds Remaining
The Miami Project (TMP) to Cure Paralysis, a Center of Excellence at the University of Miami Miller School of Medicine, is considered the premier investigative research program conducting cutting edge discovery, translational & clinical investigations targeting spinal cord & brain injuries. TMP’s international team includes more than 300 scientists, researchers, clinicians & support staff who take innovative approaches to the challenges of spinal cord & brain injuries. TMP’s clinical trial program currently includes autologous Schwann cell transplantation, therapeutic hypothermia, Riluzole, deep brain stimulation & brain machine interface. Our discovery program is investigating immune modulation, scar formation & regeneration mechanisms after injury to better enable development of future interventions. In 1985, Barth A. Green, M.D. & NFL Hall of Fame linebacker Nick Buoniconti helped found TMP to Cure Paralysis after Nick’s son, Marc, sustained a spinal cord injury during a college football game. Since then research at TMP has changed the landscape of knowledge & therapeutic strategies for spinal cord injury & traumatic brain injury. Committed to finding a cure for paralysis resulting from spinal cord injury & to seeing millions worldwide walk again, the Buoniconti family established The Buoniconti Fund to Cure Paralysis in 1992, a non-profit organization devoted to assisting TMP achieve its national & international goals.
1095 NW 14TH TER
MIAMI, FL 33136-1060
Recent neuroscience discoveries have helped change the way we treat people with neurological disorders. This success is the result of a focused bench-to bedside approach to advance novel ideas and treatments. Several Miami Project initiated clinical trials are actively moving forward showing safety and efficacy. New multicenter therapeutic hypothermia clinical trials will treat acutely injured patients with severe spinal cord or traumatic brain injury. Both of these exciting multicenter trials are based on findings originally conducted by Miami Project researchers that could change the way we treat acutely injured patients.